SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CANGENE CORP
(NQPK:CGNOF Last Sale: 2.0413 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (CGNOF : $2.0413)
$136 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Winnipeg, MB, Research Report Earnings Snapshot - Last
Canada Annual Reports


fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. Four of our hyperimmune products have been approved in the United States and/or Canada, and three products are included in the U.S. Strategic National Stockpile.
Historical Charts    Technical Analysis
No Historical Data available for CGNOF

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CGNOF $2.0413 $ 0 $2.0413 $2.046 300 $1.548 $3.12 66,746
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $136,249

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex